Latest Financials News

Life360 has increased its convertible notes offering to $275 million, introducing capped call transactions to manage dilution risks as it prepares for potential growth investments.

Robex Resources Inc., a Canadian gold explorer and producer with key assets in West Africa, has launched a fully underwritten initial public offering (IPO) on the ASX to raise A$120 million. The capital will primarily support the development of its advanced Kiniero Gold Project in Guinea, alongside ongoing operations at the Nampala Mine in Mali.

Indiana Resources confirms receipt of settlement payments from Tanzania but moves to arbitration after a tax dispute threatens the agreement. The company awaits Australian tax approval to return capital to shareholders.

HITIQ Limited has pushed back the closing date for its entitlement issue offer to June 20, adjusting the timeline for its capital raising efforts.

Manuka Resources is poised to restart silver production at its Wonawinta Mine targeting 13.2 million ounces, while progressing its large-scale vanadium-titanium-magnetite project in New Zealand with a robust $1.26 billion valuation.

Kore Potash is advancing negotiations on a critical financing term sheet with the Summit Consortium for its Congo potash projects, signaling a pivotal step toward project development.

Tasmea Limited has announced a fully franked special dividend of AUD 0.12 per share, payable on 30 June 2025, alongside a Dividend Reinvestment Plan offering a 5% discount on new shares.

Tasmea Limited has declared a fully franked special dividend of 12 cents per share, reflecting robust financial performance and strong confidence in future growth prospects.

High-Tech Metals Limited has successfully completed a modest capital raise through a non-renounceable entitlement offer, issuing shares at $0.15 each alongside free attaching options. The company now holds discretion over a significant shortfall placement, which could influence its capital structure in the coming months.

Codeifai Limited has locked in $570,000 through a discounted share placement, aiming to fuel its digital platform growth and strategic initiatives.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Scorpion Minerals has completed detailed pre-drilling exploration at its Pharos Gold Project in Western Australia and is poised to begin RC drilling targeting multiple high-grade gold zones along a prolific shear corridor.